Rights and permissions
About this article
Cite this article
Insulin analogues worth the extra cost in type 1 DM. Pharmacoecon. Outcomes News 456, 3–4 (2004). https://doi.org/10.2165/00151234-200404560-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404560-00004